Bambusa Therapeutics (NASDAQ:BBTX) Stock: Insider Helmut Wolfgang Jeggle Purchases 375,000 Shares

Bambusa Therapeutics, Inc. (NASDAQ:BBTX - Get Free Report) Director Helmut Wolfgang Jeggle bought 375,000 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The shares were bought at an average price of $16.00 per share, with a total value of $6,000,000.00. Following the completion of the acquisition, the director directly owned 9,264,301 shares in the company, valued at $148,228,816. This trade represents a 4.22% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Bambusa Therapeutics Stock Performance

BBTX opened at $16.00 on Tuesday. Bambusa Therapeutics, Inc. has a 1 year low of $13.60 and a 1 year high of $16.06.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Bambusa Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Bambusa Therapeutics and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles